Physician profile
Jared W Brown
NPI 1063951606
$5,629.96
in general payments reported to CMS, 2019-2025
40 companies · $1,685 in 2025
The $1,685 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $640 · 2023: $1,830 · 2024: $1,475 · 2025: $1,685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,990.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,990.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $621.67 | 2022-2025 | Interstim |
| Boston Scientific Corporation | $563.17 | 2022-2025 | General - Erectile Dysfunction, Lithovue, Axonics |
| Sumitomo Pharma America, INC. | $549.95 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $467.23 | 2022-2024 | Xiaflex, Aveed, Edex |
| Endo USA, INC. | $454.57 | 2024-2025 | Xiaflex, Aveed |
| Pfizer INC. | $262.44 | 2023-2025 | |
| Urogen Pharma, INC. | $254.01 | 2024-2025 | |
| Astellas Pharma US INC | $215.19 | 2023-2025 | Myrbetriq, Xtandi |
| Procept Biorobotics Corporation | $170.94 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Dendreon Pharmaceuticals LLC | $160.49 | 2024 | Provenge |
| Immunitybio, INC. | $156.76 | 2025 | |
| Axonics, INC. | $129.77 | 2023 | Axonics |
| Calyxo, INC. | $125.51 | 2025 | Cvac Aspiration System |
| Myriad Genetic Laboratories, INC. | $120.60 | 2024 | Prolaris |
| Olympus America INC. | $118.83 | 2024-2025 | Itind System |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $114.42 | 2023-2025 | Titan, Speedicath |
| Antares Pharma, INC. | $110.79 | 2024-2025 | Xyosted |
| Janssen Scientific Affairs, LLC | $104.28 | 2025 | |
| Ferring Pharmaceuticals INC. | $103.17 | 2024-2025 | Adstiladrin |
| Halozyme INC | $88.33 | 2023 | |
| Merck Sharp & Dohme LLC | $77.35 | 2023-2024 | Keytruda, Welireg, Lynparza |
| Abc Home Medical Supply, INC. | $70.39 | 2023-2025 | |
| Laborie Medical Technologies Corp. | $58.59 | 2024-2025 | Injetak Adjustable Tip Needle 70cm |
| C. R. Bard, INC. & Subsidiaries | $53.88 | 2023-2024 | Bard Urinary Drainage Bag |
| 180 Medical, INC. | $47.07 | 2022-2023 | Gentlecath |
| Abbvie INC. | $41.64 | 2022-2024 | |
| Urovant Sciences INC | $38.07 | 2022 | |
| Rochester Medical Corporation | $35.45 | 2022 | |
| Convatec INC. | $34.86 | 2024-2025 | |
| Hollister Incorporated | $34.80 | 2022-2024 | |
| Tolmar, INC. | $33.31 | 2025 | Jatenzo, Eligard |
| Novartis Pharmaceuticals Corporation | $32.62 | 2025 | |
| Telix Pharmaceuticals | $25.46 | 2025 | Illuccix |
| Verity Pharmaceuticals INC. | $24.85 | 2025 | Tlando |
| Janssen Biotech, INC. | $24.48 | 2025 | Erleada |
| Azurity Pharmaceuticals, INC. | $24.02 | 2025 | Azmiro |
| Accord Healthcare, INC. | $22.28 | 2025 | |
| Photocure INC | $21.98 | 2024 | Cysview |
| Progenics Pharmaceuticals, INC. | $19.92 | 2025 | |
| Teleflex LLC | $16.82 | 2023 | Urolift |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.